Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS? by Glenda E Gray, Fatima Laher, Tanya Doherty, Salim Abdool Karim, Scott Hammer, John Mascola, Chris Beyrer, Larry Corey

Get full text

Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase. by Jessica H Brehm, Yanille Scott, Dianna L Koontz, Steven Perry, Scott Hammer, David Katzenstein, John W Mellors, Nicolas Sluis-Cremer, AIDS Clinical Trials Group Study 175 Protocol Team

Get full text

Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy. by Angelina Gomes, Emily V Reyes, L Sergio Garduno, Rita Rojas, Geraldine Mir Mesejo, Eliza Del Rosario, Lina Jose, Carmen Javier, Catherine Vaughan, Yeycy Donastorg, Scott Hammer, Karen Brudney, Barbara S Taylor

Get full text

Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure. by Hong-Van Tieu, Piyarat Suntarattiwong, Thanyawee Puthanakit, Tawee Chotpitayasunondh, Kulkanya Chokephaibulkit, Sunee Sirivichayakul, Supranee Buranapraditkun, Patcharawee Rungrojrat, Nitiya Chomchey, Simon Tsiouris, Scott Hammer, Vijay Nandi, Jintanat Ananworanich, Thai TB Px Study Group

Get full text